The UK biotech Grey Wolf Therapeutics has raised €11.4M (£10M) to fuel the development of a cancer therapy that flushes tumor cells out of hiding from the immune system. Many approved cancer immunotherapies, such as CAR-T cell therapy and checkpoint inhibitors, ...
The post Series A Funds Therapy That Exposes Cancer to Immune System appeared first on Labiotech.eu.
Original Article: Series A Funds Therapy That Exposes Cancer to Immune System